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Summary
Multiple sclerosis (MS) is an organ-specific autoim-
mune disease in central nervous system, affecting
about 2.5 million people around the world. Probable
involvement of two newly identified immunoregulator
molecules, TIM-1 and TIM-3, has been reported in
autoimmune diseases. In this study, for the first time,
the association of TIM-1 5383-5397ins/del and TIM-3
-1541C>T polymorphisms with MS in an Iranian pop-
ulation was considered. The results of our study
showed that there is no significant association between
TIM-1 5383-5397ins/del and MS (P = 0.38); however,
the frequency of CT genotype of TIM-3 -1541C>T in
patient group was significantly higher than the control
group, and there was a significant association between
CT genotype and MS (P = 0.009, OR = 4.08).
Introduction
Multiple sclerosis (MS) is an organ-specific disease and
one of the most common inflammatory diseases of the
central nervous system (CNS). In this disease, innate
and acquired immune systems attack the myelin sheath
of nerve cells (Alatab et al., 2011). According to avail-
able data, about 2.5 million people around the world
are suffering from this disease (Alatab et al., 2011).
MS is a multifactorial disease. Environmental factors.
have important roles in the disease development (Lor-
entzen et al., 2010). Also, some of single nucleotide
polymorphisms (SNPs) that are associated with MS
disease were identified using genomewide association
studies (GWAS) such as polymorphism in IL-7R, IL-
2R, CD58, STAT3 genes (Freeman et al., 2010;
Sadovnick, 2012).
The T-cell/transmembrane immunoglobulin and
mucin (TIM) gene is one of the genetic factors that
recently demonstrated that has a critical role in vari-
ous diseases like autoimmune diseases. TIM gene fam-
ily, cloned in 2001 using a congenic mouse model of
asthma, plays a critical role in regulating immune
responses such as transplant tolerance, autoimmunity,
allergy and asthma (Freeman et al., 2010). The TIM
gene family consists of three members, TIM-1, TIM-3
and TIM-4, on human chromosome 5q33.2, located in
a chromosomal region linked with asthma, allergy and
autoimmunity (Rodriguez-Manzanet et al., 2009;
Yeung et al., 2011). This gene encodes type I cell-sur-
face glycoprotein with common structural features
(Lee et al., 2011). The expression pattern of TIM1,
TIM-3 and TIM4 is different in the cells; therefore,
they have different effects on the regulation of immune
responses (Yeung et al., 2011).
In human, TIM-1 is expressed on Th2 cells and func-
tions as a co-stimulatory signal for the T-cell activation
and cytokine production. Moreover, TIM-1 is
expressed on mast cells, tubular epithelial cells and a
subpopulation of B cells (Xu et al., 2008). TIM-3 is
preferentially expressed on Th1, Tc1 and also
expressed on Th17 cells, and functions as a negative
regulator for immune responses of these cells (Xu
et al., 2008, 2011). TIM-3 is also expressed on innate
immune cells like dendritic cells (DC) and can mediate
phagocytosis of apoptotic cells and cross-presentation
of antigen (Rodriguez-Manzanet et al., 2009). Interac-
tion of TIM-3 with galectin-9 (as a ligand of TIM-3)
can lead to activation of TIM-3⁄galectin-9 pathway and
downregulation of the Th1 responses (Xu et al., 2011).
Identification of different polymorphisms in TIM
genes, the way they affect immune responses and their
association with allergic and autoimmune diseases can
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create new perspectives in diagnosis and prognosis of
these diseases. In this research, we tried to investigate
the frequency of two selected polymorphisms of TIM-
1 and TIM-3 genes (5383-5397ins/del and -1541 C>T,
respectively) in patients with MS compared with the
healthy subjects in Isfahan province, Iran. Before stud-
ies have investigated the association of these two SNPs
with other autoimmune diseases like RA and their
findings were contradictory. As the pathogenesis of
RA is like the MS disease, so we have performed this
study.
Materials and methods
The study population
One hundred and thirty-eight nonrelative relapsing-
remitting multiple sclerosis (RRMS) patients that their
disease had been approved by a neurologist through
McDonald’s criteria were selected. Patients had been
attended to Alzahra hospital, Isfahan, Iran and had at
least two relapse and partial or complete remission
with 0–10 expanded disability status scale (EDSS).
One hundred and thirty-eight nonpregnant healthy
people with no manifestation of autoimmune and
inflammatory diseases and no history of organ trans-
plantation were randomly selected in Blood Donation
Organization. Two groups were matched for age and
sex.
Sample preparation and DNA extraction
Whole blood samples were taken from all subjects in
EDTA test tubes (Cinnagen Co., Karaj, Iran). The geno-
mic DNA was extracted from each sample using Geno-
mic DNA Extraction Kit (Qiagen Inc., Gladbach,
Germany) according to the manufacture’s instruction.
The quality and quantity of the extracted DNA were
assessed by electrophoresis on 1.5% agarose gel and
measuring optical density (OD) at 260 nm, respectively.
Genotyping of -1541 C>T polymorphism of TIM-3
The –1541 C>T polymorphism was genotyped by
PCR-RFLP analysis. The primers used to amplify the
fragments of TIM-3 promoter containing the SNP, -15
41C>T, were 50-TCCAGCCTGAGGCTCTTGTTT-30
and 50-ATGCTCATTGTTGTTGGAACAG-30. PCR was
carried out in a total volume of 30 lL PCR mixture
containing 150 ng of genomic DNA, 3 lL of 109
PCR buffer, 200 lM of dNTPs, 0.5 lM of each pri-
mers, 1.5 mM of MgCl2 and 1.5U of Taq DNA poly-
merase (Cinnagen Co.). The DNA was amplified with
an initial denaturation at 94°C for 5 min followed by
30 cycles at 94°C for 30 s, 57 C for 30 s, 72 C for
30 s and a final extension at 72 C for 5 min using
Techne thermal cycler (Techne Co., Minneapolis, MN,
USA). BsaJI restriction enzyme (Fermentas Co., Wurt-
temberg, Germany) was used for genotyping the SNP.
A total of 10 lL of the 199 base pair (bp) PCR pro-
duct was incubated 2 h in 56°C with 1 lL of BsaJI
enzyme. Digested products were separated on 1.5%
agarose gel. Fragments 61 and 138 bp indicated the
presence of homozygous CC genotype, a single 199 bp
band represented the presence of homozygous TT
genotype and three fragments of 61, 138 and 199 bp
displayed the presence of heterozygous CT genotype
(Figure 1).
Some genotypes were randomly selected and sent
for sequencing to ensure the accuracy of genotyping
by digestion (Bioneer Co., Daejeon, South Korea).
Genotyping of 5383-5397ins/del polymorphism of TIM-1
The 5383-5397ins/del polymorphism of TIM-1 was
genotyped by PCR-PAGE analysis (SSP-PCR). PCR
amplification was performed using following specific
primers: 50-TCCAGCCTGAGGCTCTTGTTT-30 and
50-ATGCTCATTGTTGTTGGAACAG-30. Amplifying
of DNA was carried out with the same condition for -
1541C>T in the TIM-3 gene. The PCR products were
separated on 8% denatured polyacrylamide gel and
visualized with silver nitrate staining. A 186 bp band
indicates del/del, 186 bp and 201 bp bands indicate
del/ref, fragments 201 bp and 204 bp represent ref/ins,
a 201 band indicates ref/ref, and a band with 204 bp
represents ins/ins genotypes (Figure 2).
Some genotypes were randomly selected and sent
for sequencing to ensure the accuracy of the results
(Bioneer Co.).
Statistical analysis
The SPSS 16.0 software package (SPSS Company,
Chicago, IL, USA) was used for data analysis. The
chi-squared test was used to compare the frequency
distribution of age and sex as well as genotype and
allele distributions between two groups. Association
between two polymorphisms with multiple sclerosis
was shown as odds ratios (OR) estimates with 95%
confidence intervals (95% CI). Also, logistic regression
analysis was used for evaluation the effects of -1541
Figure 1. PCR-RFLP analysis of TIM-3-1541 C>T polymorphism.
Lane M: 50 bp DNA lader; Lanes 1, 2, 3 and 6: heterozygous CT
genotype; Lanes 4 and 5: homozygous CC genotype.
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C> T SNP and 5383-5397 ins/del polymorphism on
the incidence of MS. P value <0.05 was considered as
significant in all of the tests.
Results
In this study, 138 patients with MS and 138 healthy
subjects were studied as case and control groups,
respectively. The characteristics of the two groups are
summarized in Table 1. Both groups were matched for
age and sex suitably. The genotype distributions of the
TIM-3 -1541C>T and TIM-1 5383_5397ins/del poly-
morphisms were in agreement with Hardy–Weinberg
equilibrium (P > 0.05) in both groups. The genotypes
and alleles frequency of TIM-1 5383-5397ins/del are
shown in Tables 2 and 3, and the frequency of the
genotypes of TIM-3 -1541C>T is shown in table 4.
These frequencies were compared between two groups
using the Pearson chi-squared test. Frequency of Ins
allele in patients with MS was higher than the control
group, but the frequency of different genotypes of
TIM-1 5383-5397ins/del in patient and control groups
showed no significant differences, and therefore, there
was no significant association between this polymor-
phism and the incidence of MS (P = 0.38). The fre-
quency of CT genotype of TIM-3 -1541C>T in MS
group was significantly higher than the control group,
and there was a significant association between CT
genotype and incidence of MS (P = 0.009,
OR = 4.08).
Discussion
Multiple sclerosis is one of the most common inflam-
matory diseases of the CNS which is due to immune
response to myelin sheath of nerve cells and character-
ized by degradation of the myelin sheath and loss of
oligodendrocytes, resulting in impaired nerve conduc-
tion (Weinshenker, 1996; Alonso et al. 2007). The bal-
ance between Th1/Th2 cells is important in the
immune responses. The studies in past years have
defined the role of Th1/Th2 balance in the induction
and regulation of autoimmune diseases (Charlton &
Lafferty, 1995; Nicholson & Kuchroo, 1996; Kidd,
2003). TIM genes are one of the genetic factors that
recently demonstrated that have critical roles in Th1/
Th2 responses and autoimmune diseases like MS
(Anderson & Anderson, 2006).
In this study, the frequency and the association of
two polymorphisms of TIM genes, TIM-1 5383-
5397ins/del and TIM-3 -1541C>T, with MS disease
was investigated in an Iranian population. According
to our survey in data banks, there was no report for
the association of these polymorphisms with MS.
However, findings about correlation of other
Figure 2. The results of PCR-PAGE of TIM-1 5383-5397 ins/del poly-
morphism. Lane 1: 200 bp Marker, Lane 2:del/del Lanes 3 and 5:ins/
del, Lane 4:ins/ins, Lane 6: ref/del 7:ins/ref.
Table 1. Characteristics of the studied population
Variables Control (%) Case P value
Age (Mean SD) 31.3  6.6 32.1  8.4 0.36
Sex
Male 60 (43.47) 51 (36.95) 0.2
Female 78 (56.53) 87 (63.05)
EDSS n (%)
1 91 (65.9%)
1.5 24 (17.5%)
2 14 (10.1%)
3–5 9 (6.5%)
Table 2. Comparison of allele frequency of TIM-1 5383-5397ins/del
between patients with MS and healthy subjects (n = 138)
Allele Type
MS group
(n/%)
Control
group (n/%) P value OR (CI 95%)
ref 11 (8) 8 (5.8) 0.48 1.41 (0.55–3.61)
del 120 (87) 127 (92) 0.17 0.58 (0.26–1.27)
ins 79 (57.2) 65 (47.1) 0.046 1.54 (1.04–2.42)
Total 210 (100) 200 (100)
Table 3. Comparison of genotype frequency of TIM-1 5383-5397ins/
del between patients with MS and healthy subjects (n = 138)
TIM-1 Genotype
MS group
(n/%)
Control
group (n/%) P value OR (CI 95%)
ref/ins 7 (5.1) 5 (3.6) 0.55 1.4 (0.4–4.56)
ref/del 4 (2.9) 3 (2.2) 0.7 1.3 (0.3–6.1)
ins/ins 11 (8) 6 (4.3) 0.2 1.9 (0.6–5.3)
del/del 55 (39.9) 70 (50.7) 0.09 0.7 (0.4–1.03)
ins/del 61 (44.2) 54 (39.1) 0.4 1.2 (0.7–1.9)
Ref/ref – – – –
Total 138 (100) 138 (100)
Table 4. Comparison of genotype frequency distribution of TIM-3
gene between patients with MS and healthy subjects (n = 138)
Genotype
MS group
(n/%)
Control
group (n/%) P-value OR (CI 95%)
CC 123 (89.1) 134 (97.1)
CT 15 (10.9) 4 (2.9) 0.009 4.08 (1.32–12.64)
TT – –
Total 138 (100) 138 (100)
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autoimmune diseases with this polymorphism pro-
moted us to do a study on this matter.
The results of this study show higher frequency of
‘Ins’ allele of TIM-1 5383-5397 ins/del in MS patients
compared with control group. However, no significant
difference was observed in genotype frequencies
between the two groups. Therefore, there is no signifi-
cant association between TIM-1 5383-5397ins/del and
MS disease (P = 0.38). A study in 2006 has been
conducted for possible association between TIM-1
5383-5397ins/del and RA in Korean population, but its
findings are not consistent with our results. Chae et al.
have shown that the TIM-1 5383-5397del/del is associ-
ated with a reduced risk of developing rheumatoid
arthritis (RA) in Korean population (Chae et al.,
2004a,b). This diversity may be due to the difference in
sample size, ethnic diversity and interaction of environ-
mental factors which may affect the impact of this
polymorphism as a predisposing factor in different
geographic area.
Also, the frequency and the association of TIM-3 -
1541C>T was investigated with MS in this study. The
results showed that frequency of CT genotype of TIM-
3 -1541C>T in MS group was significantly higher than
the control group, and there is a significant association
between CT genotype and incidence of MS
(P = 0.009, OR = 4.08). Based on our survey in litera-
tures, there was no report for association of TIM-3 -
1541C>T polymorphism with MS, but few studies
have investigated for correlation of this polymorphism
with other autoimmune diseases which their results
were contradictory. The study on China’s Hui popula-
tion in 2004 showed that -1541C>T polymorphism is
associated with RA which is consistent with our
results. As the mechanism of pathogenesis of RA and
MS diseases is somehow similar, it could be assumed
that this polymorphism in TIM-3 may dampen its
activity which in turn enhances Th1-mediated inflam-
mation. However, another study on China’s Han pop-
ulation in 2004 showed that there was no significant
association between TIM-3 -1541C>T polymorphism
with RA which is not consistent with our findings
(Chae et al., 2004a,b). These different findings may be
due to different ethnicity. Also, one can conclude that
the impact of this SNP is not suppressed by environ-
mental factors in our area. So, more studies in other
populations can help to clarify the role of such TIM
gene polymorphisms in MS disease.
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